Cargando…
ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile
CD47 is a widely expressed cell surface protein that functions as an immune checkpoint in cancer. When expressed by tumor cells, CD47 can bind SIRPα on myeloid cells, leading to suppression of tumor cell phagocytosis and other innate immune functions. CD47-SIRPα signaling has also been implicated in...
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104973/ https://www.ncbi.nlm.nih.gov/pubmed/30133535 http://dx.doi.org/10.1371/journal.pone.0201832 |